Shikhar Dhawan likely to captain India in limited-overs series against Sri Lanka

KEY STORY

  • Senior opener Shikhar Dhawan is likely to lead Team India on the upcoming tour of Sri Lanka in July this year. BCCI will be sending a second-string squad for the tour with Virat Kohli & Co. heading to England next month for the World Test Championship (WTC) final followed by the five-match Test series against Joe Root’s men.
  • In the absence of Kohli and his deputy Rohit Sharma, Dhawan will be captaining the side, as per a report in IANS. The white-ball squad for the Sri Lanka series will also feature the likes of Hardik Pandya, Bhuvneshwar Kumar, and Prithvi Shaw among others, who missed out on a spot in the Test side for the England series. Kuldeep Yadav, Suryakumar Yadav, and Ishan Kishan are also likely selections.
  • Both Suryakumar and Kishan had featured in the white-ball series against England at home earlier this year, where they made their respective debuts. They both were seen in action for Mumbai Indians in the now-suspended Indian Premier League (IPL) 2021 and are expected to make the cut. Some of the youngsters who did well in IPL might also get a spot in the squad.
  • The likes of Rahul Chahar, Devdutt Padikkal, Ruturaj Gaikwad, Harshal Patel among others can feature in the limited-overs squad. Apart from them, T20 specialists like Deepak Chahar, Krunal Pandya will also make the cut in the squad. India will play three ODIs and three T20Is at a single venue in Sri Lanka.

CONCLUSION

  • The series will be an important one for the Men in Blue ahead of the T20 World Cup in October. As per IANS, Dhawan is the best bet to lead Team India on the Sri Lanka tour with the kind of experience he posesses. Dhawan had also led Delhi in the domestic circuit and Sunrisers Hyderabad in the Indan Premier League.
  • Dhawan was the deputy to Rohit when the Hitman captained India in Asia Cup 2018. Besides Dhawan, KL Rahul will be a major contender for the captaincy spot if he fails to make it in time for the England series due to fitness issues.

UP: Dozens of bodies floating in Yamuna river trigger panic among locals; COVID fear looms

KEY STORY

  • Hamirpur: Amid rapid spike in COVID-19 infections in Uttar Pradesh, dozens of bodies floating in the Yamuna river were spotted by the locals in the Hamirpur district on Sunday.
  • The incident has triggered panic among the residents as they suspected the bodies to be that of the villagers who had succumbed to the deadly contagious virus.
  • As cremation grounds are running out of space owing to a surge in COVID-19 fatalities, many locals believe that bodies are being floated on the river owing to overflowing crematoriums.
  • As per a report in India Today, as the local administration discovered dozens of bodies, they decided to dump them in the Yamuna river.
  • A case has also come to light in one of the districts in Uttar Pradesh where people are cremating bodies along river banks. Owing to such instances, many deaths in Uttar Pradesh have gone unreported.
  • Locals added that deaths are being reported from rural areas across Hamirpur and Kanpur districts. The villagers are dumping the bodies of COVID victims in the Yamuna river.
  • Anoop Kumar Singh, Assistant Superintendent of Police, Hamirpur added that “The Yamuna river flows as a border between Hamirpur and Kanpur. Locals consider the river sacred and there is an old ritual of the bodies of deceased villagers being floated in the river,” as quoted by India Today.
  • He added that dozens of bodies floating in the Yamuna waters amid the second COVID wave indicate an unprecedented rise in the number of fatalities. Earlier, one or two dead bodies were occasionally seen in the river waters.
  • Singh said the villagers fearing COVID-19 are preferring to float the bodies instead of cremating them, which in turn is resulting in surge in the number of bodies floating in the river.

Another similar case in Bihar

A shocking incident was reported from Katihar in Bihar where the bodies of Covid victims were dumped into the rivers. A probe has been ordered to look into the matter where hospital staff are dumping bodies in the river. The report states that most of these Covid bodies were unclaimed so authorities tried to float them in the river.

Bharat Biotech’s Covaxin recommended by expert panel for phase II / III trials on 2-18 year-olds

KEY STORY

  • Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said.
  • The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
  • The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
“After detailed deliberation, the committee recommended for conduct of proposed phase II/III clinical trial of whole virion inactivated coronavirus vaccine in the 2 to 18 years age group subject to the condition that the firm should submit the interim safety data of phase II clinical trial along with DSMB recommendations to the CDSCO before proceeding to phase III part of the study,” a source said.

CONCLUSION

  • Earlier the proposal was deliberated in the SEC meeting dated February 24 and the firm was asked to submit a revised clinical trial protocol.
  • Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used in adults in India’s ongoing COVID-19 vaccination drive.

Karnataka adds new medicines to Covid treatment protocol

KEY STORY

  • As the intense second Covid-19 wave continues to ravage the state, the State Government is adding new medicines to the treatment protocol. Baricitinib tablets of 1mg, 2mg and 4mg strength, manufactured by Natco Pharma and approved by the Central Drugs Standard Control Organisation for emergency use, is one of the drugs that has been included.
  • Baricitinib is used in combination with Remdesivir. It is administered orally and inhibits the intracellular signalling pathway of cytokines known to be elevated in severe Covid cases.The state allowed the use of the drug three days ago on some oxygenated patients, along with other drugs that were already in the treatment protocol. The experts saw a reduction in oxygen requirement among patients.
  • Dr Anoop Amarnath, Head, Scientific Board and Chairman-Geriatric Medicine, Manipal Hospital and member of state’s Critical Care Support Team, said, “The treatment involves Baricitinib 4mg tablet given once daily for 14 days. We are doing a procalcitonin level check to rule out infection before administering the medicine. Very early data seems promising with reduction in oxygen requirement.”
  • Another emergency approval medicine is Regeneron. In the New England Journal of Medicine, a study showed that REGN-COV2 antibody cocktail reduced viral load, with a greater effect in patients whose immune response had not yet been initiated or who had a high viral load at baseline. Safety outcomes were similar in the combined REGN-COV2 dose groups and the placebo group.

CONCLUSION

  • “Regeneron has not been made available yet. We are expecting the availability and approval in the last week of May. The medicine is given to mild and moderate patients to prevent them from entering the severity stage. This drug will also be used along with the regular treatment protocols,” Dr Amarnath said.
  • Another drug, approved by the Drugs Controller General of India and developed by Defence Research Development Organisation, is 2-deoxy-D-glucose (2-DG). The clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Dr Amarnath, however, didn’t comment on the drug.

GOQii launches Vital 4 fitness tracker with blood oxygen monitor at Rs 4,999

KEY STORY

  • GOQii has introduced its new fitness tracker, Vital 4, in India, which features SPO2, blood pressure and heart-rate monitors. In addition, the fitness tracker brings IP68 dust and water resistance and up to seven days of battery life.

GOQii Vital 4

  • The GOQii Vital 4 appears to have a similar-looking design to its predecessor. As far as the specs of this fitness tracker are concerned, the device features a rectangular OLED display with a resolution of 120×120 pixels. The device has many health-related features that allow the user to track heart rate, Blood Oxygen level, body temperature, Blood Pressure, sleep, and more.
  • In addition to that, the fitness tracker also brings support for exercise modes like walking, running, workout, cycling, volleyball, tennis, table tennis, dance, basketball, cricket, yoga, relaxation, situps, soccer, climbing, aerobics, and jumping rope.
  • Moreover, the GOQii Vital 4 also has features like a phone finder, music finder and notifications for messages, calls, chat apps. The watch also gets plenty of watch faces to choose from.
  • GOQii claims up to 7 days of battery life in everyday usage, up to 3-4 days of juice when all functions are enabled. The battery life can also be extended to 7-8 days by switching off continuous heart rate and temperature monitoring.

CONCLUSION

  • The GOQii Vital 4 is available on GOQii online store and Amazon. It is available at Rs 4,999 and comes in three different strap colour options Black, Purple, and Red.
  • The sub 5K category in the fitness tracker segment has become pretty crowded with some good wearables like Honor Watch ES, Amazfit Bip U Pro, Realme Watch S, Noise ColorFit Pro 3 and more. Hence, it will be interesting to find out how GOQii Vital 4 fares against potential competitors.

Build Your Immunity to Fight Covid: Saunf, jeera, haldi powder

KEY STORY

  • During the Covid crisis, self-preservation is the key. It is important to stay healthy for each one of us in order to help those in need. In today’s segment of Build Your Immunity to Fight Covid, Dr Rajesh Sharma from Delhi told IndiaToday.in about a simple, easy-to-make powder that helps in strengthening the immune system.
  • INGREDIENTS:

    1/4 tsp haldi powder
1/2 tsp saunf
1/4 tsp jeera
1/4 tsp ajwain
1/4 tsp coriander seeds
2 laung
1/4 tsp ginger powder

HOW TO MAKE

Take half teaspoon saunf, one-fourth teaspoon jeera, one-fourth teaspoon ajwain and one-fourth teaspoon coriander seeds in a pan. Roast these ingredients for 7 to 10 minutes. Let them cool down. Put the ingredients in a grinder and make a fine powder. Add one-fourth teaspoon haldi powder and one-fourth teaspoon ginger powder. Mix the powder well and store it in a jar.
Consume half teaspoon of this powder with lukewarm water before going to bed every day.

BENEFITS

Ajwain and Jeera

Ajwain and jeera are good for your digestive system and help in boosting immunity. They help control blood sugar and also fight bacteria and parasites.

Haldi

Haldi is a good antiseptic. It increases the antioxidant capacity of the body and helps in fighting any kind of infection.

Laung and Saunf

Laung and saunf also help in building immunity and keep the digestive system happy. If you have a good digestive system, it gets easier to fight infections and these ingredients help with the same.

Ginger powder

Ginger powder contains gingerol, which has medicinal properties. It helps in lowering blood sugar and also treats chronic indigestion.

Sara Ali Khan contributes towards Sonu Sood’s charity foundation for COVID relief; Sood says “You are a hero”

KEY STORY

  • The country is facing a surge in Covid-19 cases and Sara Ali Khan is one of the prominent voices that have been utilising their social media influence to source and provide Covid relief.
  • Now, the actress has extended her support further and donated a significant amount to Sonu Sood’s charity foundation for purchasing more oxygen cylinders for those in dire need.
  • Thanking the Sara for her contribution, Sood took to his social media and wrote, “Thank you so much my dear Sara Ali Khan for your contribution to the @soodfoundation! Extremely proud of you & keep on doing the good work. You have inspired the youth of the nation to come forward and help during these difficult times. You are a hero????@sara_ali_khan95”

CONCLUSION

  • Sara has been consistently amplifying and giving a shout-out to Covid relief requirements and resources on her social media.

Remainder of IPL 2021 not happening in India, confirms BCCI president Sourav Ganguly

KEY STORY

  • The 14th edition of the Indian Premier League (IPL) was suspended earlier this week after COVID-19 breached the bio-bubble of four franchises. At first, the BCCI rescheduled the league stage match between Royal Challengers Bangalore and Kolkata Knight Riders after 2 positive cases.
  • As the number of COVID-19 cases increased 6 in the next 24 hours, the board had no other option but to suspend the league. Since the league is suspended and not cancelled, the BCCI will aim to stage the remainder of 31 matches whenever it gets the window.
  • Also, the venue of the league will be one to watch out for. The BCCI was confident of pulling off the league in India as it had successfully hosted England in a full-fledged series earlier in the year. But the number of COVID-19 cases started to increase in March and also had its impact on IPL.
  • While the BCCI will stage the remainder of IPL 2021 whenever it finds the window, board’s president Sourav Ganguly has confirmed that India will not host IPL 2021. Speaking to Sportstar, the former India captain said that the league ‘can’t happen in India’. He also revealed that Team India is scheduled to tour Sri Lanka in July for a white-ball series.
  • “No (Ganguly on IPL after WTC final). India is supposed to go to Sri Lanka for three ODIs and five T20Is. There are lots of organisational hazards like 14-day quarantine. It can’t happen in India. This quarantine is tough to handle. Too early to say how we can find a slot to complete the IPL,” he told Sportstar.

CONLUSION

  • India have a packed schedule in 2021 and as Ganguly said, it’s too early to talk about finding a suitable slot to complete IPL.
  • As per the schedule, India will leave for the UK in June for the WTC final and the five-match Test series against England, which takes place in August-September. The availability of foreign players will be one of the major factors in deciding the window for IPL 2021.

WhatsApp privacy policy goes into effect this week: What happens to your account if you do not accept it

KEY STORY

  • WhatsApp in the early days of January 2021 sent out a pop-up notification to all its users in which they enlightened them about their new changes to the privacy policy policies.
  • One of the statements read that WhatsApp will now be sharing its user data with its main application, Facebook and that WhatsApp headquarters will have access to your data, and a lot of people condemned this claiming that it was a breach of privacy.
  • As a result, many users looked for alternative messaging applications and flocked to Signal or Telegram.
  • WhatsApp, which was set to enforce its new data-sharing policy from May 15, 2021 following a delay in response to a user outcry revealed on its website that it would not immediately cut off users who do not accept the new terms, although it would send reminders to those who do not accept the terms.

     

CONCLUSION

  • Countering rumours and misinformation a WhatsApp spokesperson told PTI, “No accounts will be deleted on May 15 because of this update and no one in India will lose functionality of WhatsApp either. We will follow up with reminders to people over the next several weeks,” an emailed response to a query on Friday.
  • For those who choose not to accept the company’s updated terms, the app will continue to show a notification asking to accept. After a period of several weeks, the users will see a persistent reminder.

Hospitals directed no COVID patient be refused admission for lack of valid ID, Centre tells SC

KEY STORY

  •  All central and state government hospitals managing COVID patients have been directed to ensure that no patient is refused admission due to lack of a valid identity card and a positive test report for coronavirus, the Centre has told the Supreme Court.
  • In an affidavit on the points raised by the top court, the Centre submitted that the Ministry of Health and Family Welfare has intimated all state governments regarding the policy of setting up three-tier Health infrastructure for appropriate management of suspect/ confirmed COVID-19 cases.
  • As the vaccination of the entire country is not possible in one stretch due to the very suddenness of the pandemic and limited availability of vaccine doses, vulnerability is the prime consideration, it said.
  • The Centre’s affidavit was submitted late Sunday night in a suo motu case by the apex court for ensuring essential supplies and services during the COVID-19 pandemic.
  • It further said that the guidance document issued in this regard on April 7, 2020, envisages/mandates setting up of COVID Care Centre (CCC) for mild cases and these have been set up in hostels, hotels, schools, stadiums and lodges, both public and private.
  • “Functional hospitals like Community Health Centres (CHCs), etc, which may be handling regular, non-COVID cases may also be designated as COVID Care Centers as a last resort. Dedicated COVID Health Centre (DCHC) that shall offer care for all cases that have been clinically assigned as moderate.
  • “These should either be a full hospital or a separate block in a hospital with preferably separate entry/exit/zoning. Private hospitals may also be designated as COVID Dedicated Health Centres. These hospitals would have beds with assured Oxygen support,” the Centre said.
  • It said that a dedicated COVID hospital shall offer comprehensive care primarily for those who have been clinically assigned as severe.
  • “These hospitals should either be a full hospital or a separate block in a hospital with preferably separate entry/exit. Private hospitals may also be designated as COVID Dedicated Hospitals. These hospitals would have fully equipped ICUs, Ventilators and beds with assured Oxygen support,” it said.
  • The Centre further said: “It is submitted that the Central Government has also directed that the hospitals under the Central Government, State Governments and Union territory administrations including private hospitals (in States and UTs) managing COVID patients shall ensure — Requirement of a positive test for COVID-19 virus is not mandatory for admission to a COVID health facility if clinically hospitalisation is necessary otherwise.
  • “A suspect case shall be admitted to the suspect ward of CCC, DCHC or DHC as the case may be. No Patient will be refused services on any count. This includes medications such as oxygen or essential drugs even if the patient belongs to a different city. No patient shall be refused admission on the ground that he/she is not able to produce a valid identity card that does not belong to the city where the hospital is located.”
  • The government told the apex court that admissions to the hospital must be based on need and it should be ensured that beds are not occupied by persons who do not need hospitalisation.
  • “The Chief Secretaries of States/Union Territories have been requested to issue circulars, incorporating the above directions within three days, which shall be in force till replaced by an appropriate uniform policy.
  • “The Centre also submitted that Ministry of Health and Family Welfare has written to all the Additional Chief Secretary/Principal Secretary Health/Medical education of all States and UTs, to provide for extraordinary measures to augment the need of medical staff in the country,” the bench said.

     

CONCLUSION

  • In view of the need for increasing the availability of trained human resources to tackle the COVID-19 pandemic situation, the guidelines and directions have been issued in consultation with the National Medical Commission and the Indian Nursing Council, the Centre said.
  • “It is submitted that depending upon the progress in this direction, the Central Government shall consider other incentives without compromising with the merits which can never be compromised in the field of medicine,” it said.